One in Three Men Die Early - Androlabs Applauds new £6.3m Fund to Tackle a Worsening Crisis

Androlabs, Europe’s leading men’s health pharmaceutical company, has welcomed the UK’s new £6.3 million Men’s Health Community Fund. It comes at a critical moment, as more than one in three men in England are dying early before the age of 75. While backing the investment and its focus on community-led solutions, Androlabs said that worsening outcomes show the crisis is deepening and that bold, systemic action is now urgent.

The new men’s health fund, delivered through a partnership between government, Movember and People’s Health Trust, aims to support grassroots projects improving outcomes for men and boys, particularly those most at risk. But the scale of the challenge is stark. More than one in three men in England died before 75 in 2024, and men continue to live shorter lives than women while spending more of those years in poor health.

“Awareness of men’s health has never been higher,” said Charlie Bryant, co-founder and CEO of Androlabs. “But outcomes are still moving in the wrong direction. In 2026, too many men are still dying earlier, living sicker, and asking for help less. That’s not a marginal issue, it’s systemic.”

He pointed to a persistent gap between what we know clinically and what men actually experience in practice.

“Many conditions affecting men remain under-recognised, under-discussed, and diagnosed too late, limiting opportunities for early intervention. This is not a question of clinical efficacy, but a behavioural and systemic gap in how men engage with healthcare and how services reach them. At the same time, men are significantly less likely to seek help early, often entering the healthcare system when conditions have already progressed.”

“Too many men are living with symptoms without recognising them or without feeling able to act on them. By the time they seek help, it’s often later than it should be.

“We welcome the fund’s focus on community-led, accessible interventions, particularly its emphasis on reaching men in familiar and trusted environments. If we want to engage men, we have to meet them where they are. This approach reflects Androlabs’ own work to create more accessible entry points into men’s health conversations - from The Brothers’ Arms pop-up men’s health pub to The Men’s Health Podcast - designed to break down stigma and encourage earlier engagement.

“When we create the right environments, men are really happy to talk about their health. The challenge is turning those conversations that are enabled by communities into earlier diagnosis and meaningful care.

“Community programmes can open the door, but the healthcare system has to be ready when men walk through it. With the UK ranking just 27th globally for life expectancy and men’s healthy life expectancy declining over the past decade, the issue demands coordinated, system-wide action.

“This isn’t just about funding projects; it’s about fundamentally rethinking how we approach men’s health. We need earlier diagnosis, better awareness of overlooked conditions, and efficient systems to provide quality of life-enhancing solutions.

“It’s also important to celebrate the fund’s focus on evaluation and evidence, although the real test will be whether it delivers measurable change. We’ve moved past awareness. The question now is impact - fewer early deaths, earlier diagnoses, and more men engaging with their health.

“This fund is a strong step but it’s only the start. At Androlabs, we believe industry has a responsibility to lead as well as follow. We need to close the gap between what we know is possible and what men typically experience.”